Skip to main content
Top
Published in: Urolithiasis 5/2012

01-10-2012 | Original Paper

Quantitative analysis of colonization with real-time PCR to identify the role of Oxalobacter formigenes in calcium oxalate urolithiasis

Authors: Ertan Batislam, Erdal Yilmaz, Ercan Yuvanc, Ozgul Kisa, Ucler Kisa

Published in: Urolithiasis | Issue 5/2012

Login to get access

Abstract

The objective of the study was to quantitatively measure the number of Oxalobacter formigenes (O. formigenes) colonizations in the gastrointestinal tract in calcium oxalate-forming patients with real-time polymerase chain reaction (PCR). Calcium oxalate-forming patients (n: 27) were included in the study. Serum calcium, sodium, potassium, urea and creatinine levels, as well as 24 h urine levels of calcium and oxalate were measured. The numbers of O. formigenes colonies in stool samples were detected by real-time PCR. One or two metabolic abnormalities were detected in 15 of 27 patients. The O. formigenes levels in patients with metabolic disturbance were significantly decreased when compared to the patients with no metabolic abnormalities (p: 0.038). The undetectable levels of O. formigenes were encountered in one of five patients with hypercalciuria, in three of four patients with hyperoxaluria and in four of six patients with both hypercalciuria and hyperoxaluria. In nine patients with a history of stone recurrence, O. formigenes colonization was significantly lower than the patients with the first stone attack (p: 0.001). O. formigenes formation ceased or significantly diminished in patients with calcium oxalate stones with a coexistence of both hyperoxaluria and hypercalciuria. The measurement of O. formigenes colonies by real-time PCR seemed to be an inconvenient and expensive method. For this reason, the real-time PCR measurements can be spared for the patients with stone recurrences and with metabolic abnormalities like hypercalciuria and hyperoxaluria. The exact measurement of O. formigenes may also help more accurate programming of O. formigenes-based treatments.
Literature
1.
go back to reference Menon M, Parulkar BG, Drach GW (1988) Urinary lithiasis: etiology, diagnosis and medical management. In: Walsh PC, Retik AB, Vaughan ED Jr, Wein AJ (eds) Campbell’s Urology, vol III, 7th edn. W. B. Saunders Co., Philadelphia, pp 2659–2752 Menon M, Parulkar BG, Drach GW (1988) Urinary lithiasis: etiology, diagnosis and medical management. In: Walsh PC, Retik AB, Vaughan ED Jr, Wein AJ (eds) Campbell’s Urology, vol III, 7th edn. W. B. Saunders Co., Philadelphia, pp 2659–2752
2.
go back to reference Goldfarb DS (2009) Prospects for dietary therapy of recurrent nephrolithiasis. Adv Chronic Kidney Dis 16:21–29PubMedCrossRef Goldfarb DS (2009) Prospects for dietary therapy of recurrent nephrolithiasis. Adv Chronic Kidney Dis 16:21–29PubMedCrossRef
3.
go back to reference Borghi L, Meschi T, Maggiore U, Prati B (2006) Dietary therapy in idiopathic nephrolithiasis. Nutr Rev 64:301–312PubMedCrossRef Borghi L, Meschi T, Maggiore U, Prati B (2006) Dietary therapy in idiopathic nephrolithiasis. Nutr Rev 64:301–312PubMedCrossRef
4.
go back to reference Bruce AW, Reid G (2003) Probiotics and the urologist. Can J Urol 10:1785–1789PubMed Bruce AW, Reid G (2003) Probiotics and the urologist. Can J Urol 10:1785–1789PubMed
5.
go back to reference Duncan SH, Richardson AJ, Kaul P et al (2002) Oxalobacter formigenes and its potential role in human health. Appl Environ Microbiol 68:3841–3847PubMedCrossRef Duncan SH, Richardson AJ, Kaul P et al (2002) Oxalobacter formigenes and its potential role in human health. Appl Environ Microbiol 68:3841–3847PubMedCrossRef
6.
go back to reference Hatch M, Freel RW (2008) The roles and mechanisms of intestinal oxalate transport in oxalate homeostasis. Semin Nephrol 28:143–151PubMedCrossRef Hatch M, Freel RW (2008) The roles and mechanisms of intestinal oxalate transport in oxalate homeostasis. Semin Nephrol 28:143–151PubMedCrossRef
7.
go back to reference Mittal RD, Kumar R (2004) Gut-inhabiting bacterium Oxalobacter formigenes: role in calcium oxalate urolithiasis. J Endourol 18:418–424PubMedCrossRef Mittal RD, Kumar R (2004) Gut-inhabiting bacterium Oxalobacter formigenes: role in calcium oxalate urolithiasis. J Endourol 18:418–424PubMedCrossRef
8.
go back to reference Mittal RD, Kumar R, Bid HK et al (2005) Effect of antibiotics on Oxalobacter formigenes colonization of human gastrointestinal tract. J Endourol 19:102–106PubMedCrossRef Mittal RD, Kumar R, Bid HK et al (2005) Effect of antibiotics on Oxalobacter formigenes colonization of human gastrointestinal tract. J Endourol 19:102–106PubMedCrossRef
9.
go back to reference Sidhu H, Allison M, Peck AB (1997) Identification and classification of Oxalobacter formigenes strains by using oligonucleotide probes and primers. J Clin Microbiol 35:350–353PubMed Sidhu H, Allison M, Peck AB (1997) Identification and classification of Oxalobacter formigenes strains by using oligonucleotide probes and primers. J Clin Microbiol 35:350–353PubMed
10.
go back to reference Troxel SA, Sidhu H, Kaul P et al (2003) Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate. J Endourol 17:173–176PubMedCrossRef Troxel SA, Sidhu H, Kaul P et al (2003) Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate. J Endourol 17:173–176PubMedCrossRef
11.
go back to reference Mittal RD, Kumar R, Mittal B et al (2003) Stone composition, metabolic profile and the presence of the gut-inhabiting bacterium Oxalobacter formigenes as risk factors for renal stone formation. Med Princ Pract 12:208–213PubMedCrossRef Mittal RD, Kumar R, Mittal B et al (2003) Stone composition, metabolic profile and the presence of the gut-inhabiting bacterium Oxalobacter formigenes as risk factors for renal stone formation. Med Princ Pract 12:208–213PubMedCrossRef
12.
go back to reference Prokopovich S, Knight J, Assimos DG et al (2007) Variability of Oxalobacter formigenes and oxalate in stool samples. J Urol 178:2186–2190PubMedCrossRef Prokopovich S, Knight J, Assimos DG et al (2007) Variability of Oxalobacter formigenes and oxalate in stool samples. J Urol 178:2186–2190PubMedCrossRef
13.
go back to reference Larionov A, Krause A, Miller W (2005) A standard curve-based method for relative real-time PCR data processing. BMC Bioinformatics 21(62):1–16 Larionov A, Krause A, Miller W (2005) A standard curve-based method for relative real-time PCR data processing. BMC Bioinformatics 21(62):1–16
14.
go back to reference Sails AD (2004) Applications of real-time PCR in clinical microbiology. In: Edwards K, Logan J, Saunders N (eds) Real-time PCR: an essential guide. Horizon Biosci, Norfolk, pp 247–326 Sails AD (2004) Applications of real-time PCR in clinical microbiology. In: Edwards K, Logan J, Saunders N (eds) Real-time PCR: an essential guide. Horizon Biosci, Norfolk, pp 247–326
15.
go back to reference Neuhaus TJ, Belzer T, Blau N et al (2000) Urinary oxalate excretion in urolithiasis and nephrocalcinosis. Arch Dis Child 82:322–326PubMedCrossRef Neuhaus TJ, Belzer T, Blau N et al (2000) Urinary oxalate excretion in urolithiasis and nephrocalcinosis. Arch Dis Child 82:322–326PubMedCrossRef
16.
go back to reference Kleinschmidt K, Mahlmann A, Hautmann R (1994) Oxalate degrading bacteria in the gut: do they influence calcium oxalate stone formation? In: Ryall R, Bais R, Marshall VR (eds) Urolithiasis 2. Plenum Press, New York, pp 439–441CrossRef Kleinschmidt K, Mahlmann A, Hautmann R (1994) Oxalate degrading bacteria in the gut: do they influence calcium oxalate stone formation? In: Ryall R, Bais R, Marshall VR (eds) Urolithiasis 2. Plenum Press, New York, pp 439–441CrossRef
17.
go back to reference Hoppe B, Beck B, Gatter N et al (2006) Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1. Kidney Int 70:1305–1311PubMedCrossRef Hoppe B, Beck B, Gatter N et al (2006) Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1. Kidney Int 70:1305–1311PubMedCrossRef
18.
go back to reference Sidhu H, Schmidt ME, Cornelius JG et al (1999) Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy. J Am Soc Nephrol 10(Suppl 14):S334–S340PubMed Sidhu H, Schmidt ME, Cornelius JG et al (1999) Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy. J Am Soc Nephrol 10(Suppl 14):S334–S340PubMed
19.
go back to reference Kaufman DW, Kelly JP, Curhan GC et al (2008) Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones. J Am Soc Nephrol 19:1197–1203PubMedCrossRef Kaufman DW, Kelly JP, Curhan GC et al (2008) Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones. J Am Soc Nephrol 19:1197–1203PubMedCrossRef
20.
go back to reference Kwak C, Kim HK, Kim EC et al (2003) Urinary oxalate levels and the enteric bacterium Oxalobacter formigenes in patients with calcium oxalate urolithiasis. Eur Urol 44:475–481PubMedCrossRef Kwak C, Kim HK, Kim EC et al (2003) Urinary oxalate levels and the enteric bacterium Oxalobacter formigenes in patients with calcium oxalate urolithiasis. Eur Urol 44:475–481PubMedCrossRef
21.
go back to reference Siva S, Barrack ER, Reddy GP et al (2009) A critical analysis of the role of gut Oxalobacter formigenes in oxalate stone disease. BJU Int 103:18–21PubMedCrossRef Siva S, Barrack ER, Reddy GP et al (2009) A critical analysis of the role of gut Oxalobacter formigenes in oxalate stone disease. BJU Int 103:18–21PubMedCrossRef
22.
go back to reference Sidhu H, Holmes RP, Allison MJ et al (1999) Direct quantification of the enteric bacterium Oxalobacter formigenes in human fecal samples by quantitative competitive-template PCR. J Clin Microbiol 37:1503–1509PubMed Sidhu H, Holmes RP, Allison MJ et al (1999) Direct quantification of the enteric bacterium Oxalobacter formigenes in human fecal samples by quantitative competitive-template PCR. J Clin Microbiol 37:1503–1509PubMed
23.
go back to reference Kharlamb V, Schelker J, Francois F et al (2011) Oral antibiotic treatment of helicobacter pylori leads to persistently reduced intestinal colonization rates with Oxalobacter formigenes. J Endourol 25:1781–1785PubMedCrossRef Kharlamb V, Schelker J, Francois F et al (2011) Oral antibiotic treatment of helicobacter pylori leads to persistently reduced intestinal colonization rates with Oxalobacter formigenes. J Endourol 25:1781–1785PubMedCrossRef
24.
go back to reference Kelly JP, Curhan GC, Cave DR et al (2011) Factors related to colonization with Oxalobacter formigenes in US adults. J Endourol 25:673–679PubMedCrossRef Kelly JP, Curhan GC, Cave DR et al (2011) Factors related to colonization with Oxalobacter formigenes in US adults. J Endourol 25:673–679PubMedCrossRef
25.
go back to reference Hoppe B, von Unruh G, Laube N et al (2005) Oxalate degrading bacteria: new treatment option for patients with primary and secondary hyperoxaluria? Urol Res 33:372–375PubMedCrossRef Hoppe B, von Unruh G, Laube N et al (2005) Oxalate degrading bacteria: new treatment option for patients with primary and secondary hyperoxaluria? Urol Res 33:372–375PubMedCrossRef
26.
go back to reference Campieri C, Campieri M, Bertuzzi V et al (2001) Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration. Kidney Int 60:1097–1105PubMedCrossRef Campieri C, Campieri M, Bertuzzi V et al (2001) Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration. Kidney Int 60:1097–1105PubMedCrossRef
27.
go back to reference Watterson JD, Cadieux PA, Beiko DT et al (2003) Oxalate-degrading enzymes from Oxalobacter formigenes: a novel device coating to reduce urinary tract biomaterial-related encrustation. J Endourol 17:269–274PubMedCrossRef Watterson JD, Cadieux PA, Beiko DT et al (2003) Oxalate-degrading enzymes from Oxalobacter formigenes: a novel device coating to reduce urinary tract biomaterial-related encrustation. J Endourol 17:269–274PubMedCrossRef
28.
go back to reference Hoppe B, Dittlich K, Fehrenbach H et al (2011) Reduction of plasma oxalate levels by oral application of Oxalobacter formigenes in 2 patients with infantile oxalosis. Am J Kidney Dis 58:453–455PubMedCrossRef Hoppe B, Dittlich K, Fehrenbach H et al (2011) Reduction of plasma oxalate levels by oral application of Oxalobacter formigenes in 2 patients with infantile oxalosis. Am J Kidney Dis 58:453–455PubMedCrossRef
29.
go back to reference Hoppe B, Groothoff JW, Hulton SA et al (2011) Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria. Nephrol Dial Transpl 26:3609–3615CrossRef Hoppe B, Groothoff JW, Hulton SA et al (2011) Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria. Nephrol Dial Transpl 26:3609–3615CrossRef
Metadata
Title
Quantitative analysis of colonization with real-time PCR to identify the role of Oxalobacter formigenes in calcium oxalate urolithiasis
Authors
Ertan Batislam
Erdal Yilmaz
Ercan Yuvanc
Ozgul Kisa
Ucler Kisa
Publication date
01-10-2012
Publisher
Springer-Verlag
Published in
Urolithiasis / Issue 5/2012
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-011-0449-8

Other articles of this Issue 5/2012

Urolithiasis 5/2012 Go to the issue